Aliquots Archives
New drug mutes more melanomas
Apr. 26, 2012—An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
Neuronal clues to cholesterol-defect disorder
Apr. 20, 2012—Antioxidants may be a beneficial treatment for an inherited genetic disorder.
Pathways to delirium in the ICU
Apr. 17, 2012—Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.
Wilms’ tumors differ in developing nations
Apr. 13, 2012—In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations.
Targeting post-transplant diabetes
Apr. 12, 2012—Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.
Factor sensitizes cancer to radiation
Apr. 6, 2012—Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy.
New tool hooks heart failure drugs
Apr. 6, 2012—A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure.
Plant compound quells inflammation
Apr. 6, 2012—Berberine, an herbal remedy for diarrhea and intestinal parasites, may be an effective treatment for gastrointestinal inflammatory diseases.
Gut germs govern growth
Apr. 6, 2012—Treating H. pylori infection in children may help their growth rebound, a recent study suggests.
Smoking stokes cells’ cancer capacity
Mar. 23, 2012—Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk.
Obesity turns “good” cholesterol bad
Mar. 21, 2012—Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol.
iPOND method goes fishing for proteins
Mar. 19, 2012—A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer.
